Polysaccharide Submicrocarrier for Improved Pulmonary Delivery of Poorly Soluble Anti-infective Ciprofloxacin: Preparation, Characterization, and Influence of Size on Cellular Uptake.
Cast your vote
You can rate an item by clicking the amount of stars they wish to award to this item.
When enough users have cast their vote on this item, the average rating will also be shown.
Your vote was cast
Thank you for your feedback
Thank you for your feedback
de Rossi, Chiara
de Souza Carvalho-Wodarz, Cristiane
MetadataShow full item record
AbstractThe majority of the currently used and developed anti-infectives are poorly water-soluble molecules. The poor solubility might lead to limited bioavailability and pharmacological action of the drug. Novel pharmaceutical materials have thus been designed to solve those problems and improve drug delivery. In this study, we propose a facile method to produce submicrocarriers (sMCs) by electrostatic gelation of anionic ß-cyclodextrin (aß-CD) and chitosan. The average hydrodynamic size ranged from 400 to 900 nm by carefully adjusting polymer concentrations and N/C ratio. The distinct host-guest reaction of cyclodextrin derivative is considered as a good approach to enhance solubility, and prevent drug recrystallization, and thus was used to develop sMC to improve the controlled release profile of a poorly soluble and clinically relevant anti-infective ciprofloxacin. The optimal molar ratio of ciprofloxacin to aß-CD was found to be 1:1, which helped maximize encapsulation efficiency (∼90%) and loading capacity (∼9%) of ciprofloxacin loaded sMCs. Furthermore, to recommend the future application of the developed sMCs, the dependence of cell uptake on sMCs size (500, 700, and 900 nm) was investigated in vitro on dTHP-1 by both flow cytometry and confocal microscopy. The results demonstrate that, regardless of their size, an only comparatively small fraction of the sMCs were taken up by the macrophage-like cells, while most of the carriers were merely adsorbed to the cell surface after 2 h incubation. After continuing the incubation to reach 24 h, the majority of the sMCs were found intracellularly. However, the sMCs had been designed to release sufficient amount of drug within 24 h, and the subsequent phagocytosis of the carrier may be considered as an efficient pathway for its safe degradation and elimination. In summary, the developed sMC is a suitable system with promising perspectives recommended for pulmonary extracellular infection therapeutics.
CitationMol Pharm. 2018;15(3):1081-1096. doi:10.1021/acs.molpharmaceut.7b00967.
AffiliationHIPS, Helmholtz-Institut für Pharmazeutische Forschung Saarland, Universitätscampus E8.1 66123 Saarbrücken, Germany.
PublisherAmerican Chemical Society
The following license files are associated with this item:
- Creative Commons
- Swellable ciprofloxacin-loaded nano-in-micro hydrogel particles for local lung drug delivery.
- Authors: Du J, El-Sherbiny IM, Smyth HD
- Issue date: 2014 Dec
- Dual cross-linked chitosan microspheres formulated with spray-drying technique for the sustained release of levofloxacin.
- Authors: Zhou J, Chen Y, Luo M, Deng F, Lin S, Wu W, Li G, Nan K
- Issue date: 2019 Apr
- In-vitro and in-vivo evaluation of ciprofloxacin liposomes for pulmonary administration.
- Authors: Liu C, Shi J, Dai Q, Yin X, Zhang X, Zheng A
- Issue date: 2015 Feb
- Ocular ciprofloxacin hydrochloride mucoadhesive chitosan-coated liposomes.
- Authors: Abdelbary G
- Issue date: 2011 Feb
- Factors affecting drug encapsulation and stability of lipid-polymer hybrid nanoparticles.
- Authors: Cheow WS, Hadinoto K
- Issue date: 2011 Jul 1